Search Results - "Shirwan, Haval"
-
1
Current challenges for cancer vaccine adjuvant development
Published in Expert review of vaccines (04-03-2018)“…Although much progress has been made in the last decade(s) toward development of effective cancer vaccines, there are still important obstacles to therapeutic…”
Get full text
Journal Article -
2
Establishment of Translational Luciferase-Based Cancer Models to Evaluate Antitumoral Therapies
Published in International journal of molecular sciences (01-10-2024)“…Luciferase (luc) bioluminescence (BL) is the most used light-emitting protein that has been engineered to be expressed in multiple cancer cell lines, allowing…”
Get full text
Journal Article -
3
4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4+CD25+FoxP3+ T Regulatory Cell Suppression
Published in PloS one (06-04-2016)“…Costimulation with the recombinant SA-4-1BBL agonist of 4-1BB receptor on conventional CD4+ T cells (Tconvs) overcomes the suppression mediated by naturally…”
Get full text
Journal Article -
4
SA-4-1BBL and monophosphoryl lipid A constitute an efficacious combination adjuvant for cancer vaccines
Published in Cancer research (Chicago, Ill.) (15-11-2014)“…Vaccines based on tumor-associated antigens (TAA) have limited therapeutic efficacy due to their weak immunogenic nature and the various immune evasion…”
Get full text
Journal Article -
5
A modified surgical procedure using minimally invasive ileocolic vein perfusion in a mouse intrahepatic islet transplant model
Published in STAR protocols (17-06-2022)“…Murine intrahepatic islet transplantation is a clinically relevant but technically challenging surgical procedure because of frequent lethal postoperative…”
Get full text
Journal Article -
6
Protocol for transplanting pancreatic islets into the parametrial fat pad of female mice
Published in STAR protocols (15-03-2024)“…Although the male epididymal fat pad is an effective site for islet transplantation, females lack this tissue. Here, we present a protocol to assess the…”
Get full text
Journal Article -
7
CD4+ T cells play a critical role in the generation of primary and memory antitumor immune responses elicited by SA-4-1BBL and TAA-based vaccines in mouse tumor models
Published in PloS one (16-09-2013)“…The role of CD4(+) T cells in the generation of therapeutic primary and memory immune responses in cancer diverse immunotherapy settings remains ambiguous. We…”
Get full text
Journal Article -
8
Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth
Published in Vaccines (Basel) (01-03-2024)“…Natural 4-1BBL (CD137L) is a cell membrane-bound protein critical to the expansion, effector function, and survival of CD8 T cells. We reported the generation…”
Get full text
Journal Article -
9
Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance
Published in Nature materials (01-08-2018)“…Islet transplantation is a promising therapy for type 1 diabetes. However, chronic immunosuppression to control rejection of allogeneic islets induces…”
Get full text
Journal Article -
10
Costimulation as a platform for the development of vaccines: a peptide-based vaccine containing a novel form of 4-1BB ligand eradicates established tumors
Published in Cancer research (Chicago, Ill.) (15-05-2009)“…Vaccines represent an attractive treatment modality for the management of cancer primarily because of their specificity and generation of immunologic memory…”
Get full text
Journal Article -
11
Killer Treg cells ameliorate inflammatory insulitis in non-obese diabetic mice through local and systemic immunomodulation
Published in International immunology (01-08-2013)“…Treg cells endowed with enhanced killing activity through decoration with Fas-ligand (FasL) protein (killer Treg) have been effective in delay of hyperglycemia…”
Get full text
Journal Article -
12
SA-4-1BBL costimulation inhibits conversion of conventional CD4+ T cells into CD4+ FoxP3+ T regulatory cells by production of IFN-γ
Published in PloS one (01-08-2012)“…Tumors convert conventional CD4(+) T cells into induced CD4(+)CD25(+)FoxP3(+) T regulatory (iTreg) cells that serve as an effective means of immune evasion…”
Get full text
Journal Article -
13
Induction of tolerance using Fas ligand: a double-edged immunomodulator
Published in Blood (15-02-2005)“…Apoptosis mediated by Fas ligand (FasL) interaction with Fas receptor plays a pivotal regulatory role in immune homeostasis, immune privilege, and…”
Get full text
Journal Article -
14
Prime-boost vaccination with SA-4-1BBL costimulatory molecule and survivin eradicates lung carcinoma in CD8+ T and NK cell dependent manner
Published in PloS one (08-11-2012)“…Subunit vaccines containing universal tumor associated antigens (TAAs) present an attractive treatment modality for cancer primarily due to their safety and…”
Get full text
Journal Article -
15
4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines
Published in Cancer research (Chicago, Ill.) (15-05-2010)“…Therapeutic subunit vaccines based on tumor-associated antigens (TAA) represent an attractive approach for the treatment of cancer. However, poor…”
Get full text
Journal Article -
16
Tumor Necrosis Factor Receptors Support Murine Hematopoietic Progenitor Function in the Early Stages of Engraftment
Published in Stem cells (Dayton, Ohio) (01-07-2010)“…Tumor necrosis factor (TNF) family receptors/ligands are important participants in hematopoietic homeostasis, in particular as essential negative expansion…”
Get full text
Journal Article -
17
Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting
Published in Journal of cancer prevention (30-03-2021)“…The Division of Cancer Prevention of the National Cancer Institute (NCI) and the Office of Disease Prevention of the National Institutes of Health co-sponsored…”
Get full text
Journal Article -
18
Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice
Published in PloS one (2011)“…Disturbed peripheral negative regulation might contribute to evolution of autoimmune insulitis in type 1 diabetes. This study evaluates the sensitivity of…”
Get full text
Journal Article -
19
226.8: Targeting apoptotic pathway to eliminate Teff cells as an effective approach to prevent acute GVHD in a humanized mouse model
Published in Transplantation (01-09-2024)Get full text
Journal Article -
20
Prophylactic fenbendazole therapy does not affect the incidence and onset of type 1 diabetes in non-obese diabetic mice
Published in International immunology (01-03-2006)“…Fenbendazole (FBZ) is a common, highly efficacious broad-spectrum anthelmintic drug used to treat and limit rodent pinworm infections. However, the effect of…”
Get full text
Journal Article